The uncertainty surrounding the UK’s future with Europe is having a measurable effect on pharma. But it looks like the end is nowhere in sight.

How do we battle gut bacteria that reduce medicine efficacy?

Scientific careers are inherently unpredictable, but there are a number of steps we can take to be prepared.

The FDA has accepted TraceLink's blockchain and digital recall projects into its DSCSA Pilot Program.

Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors.

We sit down with Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career and offers some advice for budding entrepreneurs.

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Sam Herbert walks us through the past 50 years of pharma logistics.

Gene finds that the pressures of viral vector manufacturing are almost too much.

Fail to Prepare? Prepare to Fail…